Atlanta Main Office (Sandy Springs)
Alpharetta
Lawrenceville
Marietta
Fayetteville

   1-404-257-1900
1-678-366-2154
1-770-277-3361
1-770-426-8822
1-678-366-2154
 
 Home
 
 New Patient Visit
 
 Registration Forms
 
 RBA History
 
 Staff
 
 Latest News
 
 Locations
 
 Diagnosis & Treatment
 
 IVF Program
 
 PGD
 
 Egg Freezing / Fertility Preservation
 
 Egg Donation Program
 
 Surgical Options
 
 Statistics
 
 Recurrent Pregnancy Loss (RPL)
 
 Financial Information / Insurance
 
 Research Programs
 
 Resources
 
 FAQ
 
 Videos
 
 Positions Vacant
 
 Contact Us
 
 Privacy Policy

Research Programs

Ongoing Research Projects:

1, Somatic Cell Haploidization: To develop method obtaining artificial gametes for infertile patients where sperm or egg are absent (or their quality is too poor to be used for reproduction).

2, Lysed Cell Removal (LCR) from frozen-thawed cleavage-stage embryos: To improve embryo viability and to increase pregnancy rates in Cryo Embryo Transfer cycles.

3, Implementation of Pre-implantation Genetic Diagnosis (PGD) in Frozen-thawed Embryo Transfer cycles: To extend the potential use of PGD from fresh embryo transfers to cryopreserved embryos.

4, Prospective study on rHuPH20: Recombinant human hyaluronidaze enzyme (Cumulase) is demonstrated to be a superior alternative of the earlier used, animal derived product to decumulate oocytes for the ICSI procedure.

5, Diagnostic value of Pre-implantation Genetic Diagnosis (PGD) in young, infertile patients: To identify possible genetic causes of infertility related to embryos in patients younger than 35 years old.

6, PICSI sperm select dish: To explore the possible benefit of PICSI dish for Intracytoplasmic sperm injection (ICSI) procedure where sperm is selected using a naturally occurring physiological receptor (Hyaluronan, HA), in addition to the traditional sperm selection procedures.

7, Oocyte cryopreservation: To preserve fertility potential of women who have medical indication.

  • Platelet-Activating Factor (PAF) Study
    The platelet-activating factor (PAF) study has been completed. The average pregnancy rate for gonadotropin IUI cycles is >40%, nearly twice the rate of non-PAF treated IUI cycles. Additionally, we are finding a tremendous improvement in first-cycle IUI pregnancy rates.
 
Statistics
 
PAF
 
Egg Donation Seminars
 
Patient Education
 
Mailling List